Can overseas veterinary drugs brands open a Xiaohongshu account?

Direct Answer

veterinary drugs is not suitable for direct ad account opening under the current overseas-entity access table. The page should be used to judge risk, prepare alternatives and avoid promising approval before platform review.

For overseas entities, Xiaohongshu treats the category path as invitation-led or qualification-sensitive. A brand should not assume a fully self-serve route; final approval always depends on platform review.

Category Status

Documents And Review Points

• Do not position this category as a guaranteed account-opening service.
• Confirm whether the product, service or claim can be adjusted to an allowed category.
• Prepare a written risk note before any creator seeding, paid media or landing page work.
• If the brand still wants to test China demand, separate compliant content education from restricted conversion claims.

Common Rejection Risks

• The entity name, brand name, account name and product category do not match.
• The page or store used for review is not accessible, incomplete or not aligned with the submitted category.
• The ad copy makes medical, health, investment, guarantee or sensitive efficacy claims.
• The brand submits as a normal category even though the industry needs invitation, whitelist access or additional qualification review.

Recommended Path

• Run an entity and category access check before creating the submission package.
• Prepare professional account materials first, then decide whether ad account setup or special approval should happen next.
• Build the first Xiaohongshu content plan around category education, search keywords and conversion questions.
• Review documents and claims again before paid media, KOL/KOC seeding or store traffic activation.

Useful Internal Links

• Professional account verification
• Overseas ad account setup
• Industry qualification and special approval
• Account operation agency
• pet services
• pet food
• pet supplies

FAQ

Can Muxiang still help with veterinary drugs?

Yes, but the work starts with risk assessment and alternative paths, not a promise that the category can be opened directly.

Should the brand submit the account anyway?

Usually no. Submitting a restricted category without an adjusted path can waste time and create review records that are difficult to correct.

What is the safer next step?

Clarify the exact product or service scope, remove restricted claims, and decide whether another compliant category or content-only route is possible.